Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Theophylline Inhibits Capillary Degeneration in Early Diabetic Retinopathy.

Investigative ophthalmology & visual science·2026
Same author

Lysyl Oxidase Promotes Actin-Dependent Neutrophil Activation and Cytotoxicity Toward Retinal Endothelial Cells in Diabetes.

Diabetes·2025
Same author

Lysyl oxidase promotes actin-dependent neutrophil activation and cytotoxicity in diabetes: Implications for diabetic retinopathy.

bioRxiv : the preprint server for biology·2025
Same author

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature.

Journal of visualized experiments : JoVE·2025
Same author

Mechanical Regulation of Retinal Vascular Inflammation and Degeneration in Diabetes.

Diabetes·2023
Same author

Stress resilience-enhancing drugs preserve tissue structure and function in degenerating retina via phosphodiesterase inhibition.

Proceedings of the National Academy of Sciences of the United States of America·2023

Related Experiment Video

Updated: Dec 19, 2025

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
05:54

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

Published on: January 24, 2025

576

Inflammation in diabetic retinopathy.

Johnny Tang1, Timothy S Kern

  • 1Department of Ophthalmology and Visual Sciences, University Hospitals Eye Institute, Case Western Reserve University, Cleveland, OH, USA.

Progress in Retinal and Eye Research
|June 4, 2011
PubMed
Summary

Diabetic retinopathy (DR) involves retinal inflammation. Anti-inflammatory therapies show promise in inhibiting DR development, with potential applications in both early and late stages of the disease.

More Related Videos

Retinal Pathophysiological Evaluation in a Rat Model
09:11

Retinal Pathophysiological Evaluation in a Rat Model

Published on: May 6, 2022

5.1K
Characterization of a Novel Human Organotypic Retinal Culture Technique
05:51

Characterization of a Novel Human Organotypic Retinal Culture Technique

Published on: June 9, 2021

4.5K

Related Experiment Videos

Last Updated: Dec 19, 2025

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
05:54

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature

Published on: January 24, 2025

576
Retinal Pathophysiological Evaluation in a Rat Model
09:11

Retinal Pathophysiological Evaluation in a Rat Model

Published on: May 6, 2022

5.1K
Characterization of a Novel Human Organotypic Retinal Culture Technique
05:51

Characterization of a Novel Human Organotypic Retinal Culture Technique

Published on: June 9, 2021

4.5K

Area of Science:

  • Ophthalmology
  • Diabetology
  • Immunology

Background:

  • Diabetes induces retinal metabolic and physiologic abnormalities.
  • Inflammation is a key factor in the development of diabetic retinopathy (DR).
  • Existing research suggests anti-inflammatory therapies can inhibit DR progression in animal models.

Purpose of the Study:

  • To review inflammatory mediators in early and late stages of diabetic retinopathy (DR).
  • To discuss the potential of anti-inflammatory strategies for inhibiting DR.
  • To synthesize findings primarily from in vivo studies, supplemented by in vitro data.

Main Methods:

  • Literature review focusing on inflammatory mediators in diabetic retinopathy (DR).
  • Analysis of in vivo and in vitro studies investigating inflammation in DR.
  • Evaluation of anti-inflammatory therapies in the context of DR development.

Main Results:

  • Numerous molecular and physiological retinal abnormalities in diabetes align with inflammatory processes.
  • Anti-inflammatory therapies have demonstrated significant inhibition of various DR aspects in preclinical models.
  • Inflammatory mediators play a role in both early and late stages of DR.

Conclusions:

  • Inflammation is a critical component of diabetic retinopathy (DR) pathogenesis.
  • Targeting inflammatory pathways with anti-inflammatory therapies presents a promising strategy for managing DR.
  • Further research into anti-inflammatory approaches could lead to novel treatments for diabetic retinopathy.